Immediate Improvement 19 Months After Stroke at 19 Years Old After Treatment at INR in Boca Raton, Florida, in December 2016
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR. Copyright 2018 INR PLLC, all rights reserved.
Rapid improvement 7 months after stroke at the INR, October 2016
Improvement in hand function, walking, and cognition after treatment at the INR 7 months after stroke.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR.
Rapid improvement in hand function after treatment at the INR 5 years after stroke, September 2016
Patient from Georgia has rapid improvement in hand function after treatment at the INR, September 2016, 5 years after stroke!
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR.
Immediate Relief of 5 years of Chronic Stroke Pain After Treatment at the INR, September 2016
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR.
Able to Run Minutes After Treatment at the INR 2 Years after Stroke, September 2016
Patient from Oklahoma is able to run minutes after treatment by Edward Tobinick MD at the INR two years after stroke!
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR. Copyright 2016 INR PLLC, all rights reserved.
Edward Tobinick, M.D., the founder and Director of the Institute of Neurological Recovery (INR), invented the remarkable groundbreaking perispinal etanercept (PSE) treatment more than 25 years ago. As of 2026, the INR has treated patients with chronic stroke from every state in the U.S. and from 111 countries.
PSE has been successfully used in the U.S., Europe and Australia to treat thousands of stroke survivors. In addition to unprecedented neurological improvements noted in thousands of patients and multiple published peer-reviewed scientific publications, the effectiveness of PSE for treating chronic stroke is also supported by favorable double-blind, randomized, placebo-controlled, university clinical trial data.
PSE is NOT a spinal injection. PSE involves a shallow, superficial injection with a very short, thin needle that CANNOT reach the spinal canal. Anesthesia is NOT NEEDED and patients can resume all of their usual activities immediately after treatment. Patients and their families have been amazed at how easy the process is.
The INR has treated patients from every populated continent of the world.
Comments: 0